Jump to content
Script TB-500

An evidence-intensity heatmap of the TB-500 and thymosin β4 literature — every finding graded by how hot the data actually run, the cardiac signal read first, and where compounded access truly stands.

Study amounts don't set your dose

TB-500 dosage and time in your body aren't established

The fragment differs from the complete protein. Here you'll read about amounts tested and time in the body. Most amounts were given to animals. The Phase 1 early human safety test used the complete protein, leaving your amount for the fragment unknown.

TB-500 dosage can't be borrowed from another substance

A TB-500 dosage for people hasn't been established here. The figures below describe studies, not an amount for your use. Researchers mostly gave animals whole thymosin beta-4 instead of TB-500. Even the human test below gave thymosin beta-4, not TB-500.

Researchers gave rats with strokes shots into the belly [4]. Researchers tested 2, 12, or 18 milligrams per kilogram, adjusted to each rat's weight. A calculation estimated a best amount near 3.75 milligrams per kilogram; that wasn't an amount actually tested in those rats. Other brain and heart tests in rodents used roughly 6–12 milligrams per kilogram [2][4].

The largest amount didn't give rats the best result. Rats' brain function improved at 2 and 12 milligrams per kilogram of weight; rats had no gain at 18 milligrams per kilogram [4]. Increasing treatment doesn't always bring a larger gain. You can't turn these rat findings into a human amount.

Treatment made skin cells grown in laboratory dishes move more [3]. About 10 trillionths of a gram led to two-to-three times the movement of untreated cells. Tiny amounts also made cells involved in hair growth active [5]. Neither dish result tells you how much a person needs.

Healthy volunteers received whole thymosin beta-4 in an early Phase 1 safety study [6]. Different groups were assigned 42, 140, 420, or 1260 milligrams through a vein; each group had its own assigned amount, rather than daily increases. Researchers tested a single amount, then repeated daily treatment for 14 days. Harm didn't force them to halt tests of larger amounts, but that doesn't establish the fragment's safety for you.

Athletes' accounts sometimes describe a larger starting amount followed by smaller amounts. Human trials comparing treatments haven't checked those schedules [11]. The TB-500 study amounts therefore don't establish a safe human plan. You're reading what was tested, not a schedule for treating your injury.

TB-500 doesn't have a proved healing timetable for you

Rats treated with whole thymosin beta-4 grew about 42% more new skin at 4 days and up to 61% more at 7 days [3]. Some treatments went on the skin; others were shots in the belly. The findings measure rat healing with the larger protein. Your healing time with the fragment can't be calculated from those rat results.

Ways of giving treatment differ from ways of storing it

Researchers gave treatment in different ways for different tests. Researchers often injected treatment inside rats' bellies [4]. In a Phase 1 early human safety test, thymosin beta-4 went through a vein [6]. Wound and eye tests used skin treatment or eye drops [3][5], while personal research-use accounts describe muscle shots or shots under the skin without proof of benefit from human treatment comparisons.

How treatment enters your body can affect risk. FDA warned that immune system reactions may depend on the way the fragment is given. The immune system protects you from germs, but may also react against treatment. A different kind of shot doesn't automatically mean a safer treatment.

Research supplies come as dried powder. Researchers mix the powder with sterile water or water treated to limit germs, then keep the mixture refrigerated. Damage can occur when a stored mixture is thawed and frozen repeatedly. Inside your body, chemicals can break down the fragment, though less readily than the bigger protein.

A research label doesn't guarantee the substance inside [11]. Whole thymosin beta-4 weighs about 4963 daltons, while TB-500 weighs about 889 daltons. These are tiny lab weight units, and the difference reflects different substances. If the contents aren't known, you can't assume the supply matches the substance a study tested.

Ways of giving treatment differ from ways of storing it

TB-500 half-life means time until half remains, and isn't known

TB-500 half-life means the time needed for half the substance in your body to be removed. Reliable human tests of the fragment's timing are missing. The TB-500 time-in-the-body question therefore has no reliable human answer. Online timing claims don't give you a settled number.

People in an early Phase 1 vein study received whole thymosin beta-4 [6]. That larger protein lasted longer when researchers gave larger amounts. Its weight is about 4963 daltons; the fragment weighs about 889 daltons, in the tiny units labs use for weight. Horse blood and urine tests detected the fragment and its remains, rather than measuring treatment timing in people.

Forty-three parts make the full protein, while TB-500 contains seven parts. Body chemicals can break those substances down in different ways. The time needed to remove the substances is also likely to differ. You can't transfer the full protein's timing to the fragment in your body.

Published human research hasn't backed the timing claims for TB-500. A horse drug test asks whether a substance is present. That question differs from how long treatment lasts in a person. You're left without a reliable time for the fragment in your body.

TB-500 hasn't shown how long it stays in a person

The TB-500 half-life means time until the amount in your body falls by half. Sound human research hasn't established that time. In a Phase 1 vein study, larger amounts of whole thymosin beta-4 lasted longer [6]. That test used a different substance, while sports tests detect drugs rather than time human treatment.